Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fasting | 3 | 2020 | 242 | 0.890 |
Why?
|
| Energy Intake | 3 | 2020 | 427 | 0.820 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 175 | 0.610 |
Why?
|
| Patient Compliance | 1 | 2020 | 524 | 0.520 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2006 | 38 | 0.380 |
Why?
|
| Qc-SNARE Proteins | 1 | 2006 | 7 | 0.270 |
Why?
|
| Histidine | 1 | 2005 | 57 | 0.250 |
Why?
|
| Catheters, Indwelling | 1 | 2004 | 74 | 0.230 |
Why?
|
| Sulfadiazine | 1 | 2004 | 4 | 0.230 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2004 | 2 | 0.230 |
Why?
|
| Mycobacterium Infections | 1 | 2004 | 61 | 0.230 |
Why?
|
| Ureteral Calculi | 1 | 2004 | 13 | 0.220 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 83 | 0.220 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 333 | 0.220 |
Why?
|
| Mycobacterium | 1 | 2004 | 103 | 0.210 |
Why?
|
| Feeding Behavior | 2 | 2019 | 572 | 0.210 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 115 | 0.210 |
Why?
|
| Mobility Limitation | 2 | 2020 | 60 | 0.210 |
Why?
|
| Bacteremia | 1 | 2004 | 160 | 0.210 |
Why?
|
| Pilot Projects | 3 | 2020 | 1360 | 0.190 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1016 | 0.170 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 257 | 0.160 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2017 | 53 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2020 | 673 | 0.130 |
Why?
|
| Body Composition | 1 | 2020 | 590 | 0.130 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2006 | 25 | 0.130 |
Why?
|
| Self Report | 1 | 2020 | 695 | 0.130 |
Why?
|
| Age Factors | 2 | 2020 | 2885 | 0.130 |
Why?
|
| Overweight | 1 | 2019 | 473 | 0.120 |
Why?
|
| Vesicular Transport Proteins | 2 | 2006 | 82 | 0.120 |
Why?
|
| Eating | 1 | 2017 | 344 | 0.120 |
Why?
|
| Weight Loss | 1 | 2019 | 642 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1257 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 35 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 83 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6306 | 0.080 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2008 | 3 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 4595 | 0.080 |
Why?
|
| Enterotoxins | 1 | 2008 | 88 | 0.080 |
Why?
|
| Aged | 3 | 2020 | 18969 | 0.070 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 103 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2008 | 102 | 0.070 |
Why?
|
| Travel | 1 | 2008 | 121 | 0.070 |
Why?
|
| Diarrhea | 1 | 2008 | 170 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 796 | 0.070 |
Why?
|
| Escherichia coli Proteins | 1 | 2008 | 162 | 0.070 |
Why?
|
| Micelles | 1 | 2006 | 34 | 0.070 |
Why?
|
| SNARE Proteins | 1 | 2006 | 37 | 0.070 |
Why?
|
| Static Electricity | 1 | 2006 | 112 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2008 | 293 | 0.070 |
Why?
|
| Valine | 1 | 2006 | 72 | 0.070 |
Why?
|
| Organothiophosphates | 1 | 2006 | 5 | 0.070 |
Why?
|
| Leucine | 1 | 2006 | 102 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2006 | 255 | 0.060 |
Why?
|
| Humans | 11 | 2020 | 114045 | 0.060 |
Why?
|
| Tryptophan | 1 | 2006 | 136 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 522 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 197 | 0.060 |
Why?
|
| Cytosol | 1 | 2005 | 201 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 370 | 0.060 |
Why?
|
| Endosomes | 1 | 2005 | 122 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 474 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 507 | 0.060 |
Why?
|
| Protein Transport | 1 | 2005 | 391 | 0.060 |
Why?
|
| HeLa Cells | 1 | 2005 | 563 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2005 | 293 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 863 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2006 | 554 | 0.050 |
Why?
|
| Lipids | 1 | 2006 | 564 | 0.050 |
Why?
|
| Binding Sites | 1 | 2005 | 1166 | 0.050 |
Why?
|
| Male | 4 | 2020 | 55396 | 0.050 |
Why?
|
| Stroke | 1 | 2010 | 1019 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 527 | 0.050 |
Why?
|
| Female | 4 | 2020 | 59324 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1981 | 0.050 |
Why?
|
| Protein Binding | 1 | 2006 | 1888 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 1880 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 2355 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2017 | 49 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2020 | 271 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 56 | 0.040 |
Why?
|
| Immunoassay | 1 | 2017 | 95 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2017 | 74 | 0.040 |
Why?
|
| Gait | 1 | 2019 | 250 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 735 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 573 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2272 | 0.030 |
Why?
|
| Health Status | 1 | 2019 | 716 | 0.030 |
Why?
|
| Adult | 3 | 2010 | 30375 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 2464 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6077 | 0.020 |
Why?
|
| Middle Aged | 2 | 2008 | 26605 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 2343 | 0.020 |
Why?
|
| Mexico | 1 | 2008 | 162 | 0.020 |
Why?
|
| Inositol | 1 | 2006 | 23 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1690 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 9049 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 54 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 72 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2006 | 434 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 238 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 1558 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 12521 | 0.010 |
Why?
|
| United States | 1 | 2008 | 12137 | 0.010 |
Why?
|